Nina K. Sublette

A Call to Action: Nursing Leadership in HIV Prevention Through Equitable Pre-exposure Prophylaxis Access

Jenn Sobolik, Justin Alves, Nina K. Sublette, Nathaniel Albright

ABSTRACT: Pre-exposure prophylaxis (PrEP) has been an essential tool in our progress to End the HIV Epidemic. Nurses continue to be essential to the education, provisioning and advocacy for continued use of and accessibility of PrEP. ANAC aligns with the science and …

tw, us (code pays fourni par la source)

A Narrative, Qualitative Research Study of CRNA Perspectives of Practice Within the Anesthesia Care Team Model

Cindi Dabney, Todd B. Monroe, Nina K. Sublette, Michael A. Carter et autres

This research focused on the perspectives of certified registered nurse anesthetists on practice within the anesthesia care team (ACT) model. This narrative, qualitative study examined participants' perspectives on the strengths, challenges, conflict resolutions, and any other information they provided about working in …

us (code pays fourni par la source)

Policy Challenges and Resiliency Related to Ending the HIV Epidemic in the Southern and Rural United States: A Call to Action

Marik Moen, Nina K. Sublette, Justin Alves, Crystal Martin Walker

ABSTRACT: In this commentary, we describe current policy trends and their implications for the health of populations in the Southern and rural United States. We outline policy changes that threaten the prevention, care, and treatment of people at risk for HIV or …

us (code pays fourni par la source)

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

Ahizechukwu Chigoziem Eke, Jiajia Wang, Khadija Amin, David E. Shapiro et autres

The purpose of this study was to evaluate the pharmacokinetics of ritonavir-boosted fosamprenavir during pregnancy and postpartum. Amprenavir (the active moiety of fosamprenavir) and ritonavir intensive pharmacokinetic evaluations were performed at steady state during the second and third trimesters of pregnancy and …

us, br, th (code pays fourni par la source)

Comparison of two combined antiretroviral treatment regimens in the management of HIV in pregnancy: an observational study

Danielle Latrice Tate, Nina K. Sublette, Mary Emily Christiansen, Fernand Samson et autres

Objective Combined antiretroviral therapy (cART) in pregnancy traditionally included two nucleoside reverse transcriptase inhibitors plus 1 protease inhibitor (PI). Recently, integrase strand transfer inhibitors (INSTI) have been approved for use in pregnancy. We sought to compare the rate of undetectable VL near …

us (code pays fourni par la source)

Aging With HIV

Nina K. Sublette, Stephen M. Perez

Nina K. Sublette, PhD, FNP-BC, is an Assistant Professor, College of Nursing, The University of Tennessee Health Science Center, Memphis, Tennessee, USA, and Association of Nurses in AIDS Care, Policy and Advocacy Committee Co-Chairperson. Stephen Perez, PhD, RN, is an Infection Preventionist, …

ie (code pays fourni par la source)

A nursing solution to primary care delivery shortfall

Michael A. Carter, Phillip John Moore, Nina K. Sublette

Many countries project that they will have difficulty to meet their demand for primary care based on an inadequate supply of primary care doctors. There are many reasons for this, and they tend to vary by country. The policy options available to …

us (code pays fourni par la source)

Nineteen-Year-Old With Rectal Pain—Asking the Hard Questions

Nina K. Sublette, Ragan Johnson

HIV Vertical Transmission Does Not Differ When Using Protein Inhibitor or Integrase Inhibitor Antiretrovirals [17OP]

Luis M. Gómez, Nina K. Sublette, Jenny Q. Wang, Fernand Samson et autres

INTRODUCTION: HIV vertical transmission is reduced from 25% (baseline) to <2% with combined-antiretroviral therapy (cART) when the viral load (VL) near delivery is <1,000 copies/mL. For many years, the standard cART in pregnancy included 2 nucleoside reverse transcriptase inhibitors and 1 protease …

us (code pays fourni par la source)

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

Jennifer K. Jao, Deborah Kacanek, Paige L. Williams, Mitchell E. Geffner et autres

BACKGROUND: Pregnancy outcomes of perinatally human immunodeficiency virus-infected women (PHIV) are poorly defined. METHODS: We compared preterm delivery and birth weight (BW) outcomes (low BW [LBW], <2500 g), small-for-gestational-age [SGA], and BW z scores [BWZ]) in HIV-exposed uninfected infants of PHIV vs …

us (code pays fourni par la source)

Predictors of Depressive and Anxiety Symptoms among African American HIV-positive Women

Nina K. Sublette

This descriptive correlation study had four purposes: describe depressive and anxiety symptom levels in pregnant and non-pregnant African American (AA) HIV-positive women, examine the association between underlying vulnerabilities and depressive symptoms in HIV-positive AA women, determine the association between underlying vulnerabilities and …

us (code pays fourni par la source)